secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001628280-25-016824
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LENZ Therapeutics enters into $150M ATM sales agreement with TD Cowen
---------------------------------------------------------------------

- Company entered Sales Agreement with TD Securities (USA) LLC to sell up to $150M common stock via ATM offering.
- TD Cowen will act as sales agent and receive up to 3.0% of gross proceeds from shares sold.
- Shares will be issued under shelf registration statement on Form S-3 filed April 4, 2025.
- Company has no obligation to sell shares and may suspend offerings at any time.
- Agreement can be terminated by either party on 10 days' notice or immediately under certain conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/0001628280-25-016824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/lenz-20250404.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-016824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer